HSBC Holdings’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $610K | Buy |
3,617
+459
| +15% | +$78.5K | ﹤0.01% | 2127 |
|
|
2025
Q4 | $534K | Buy |
+3,158
| New | +$513K | ﹤0.01% | 2286 |
|
|
2025
Q3 | – | Sell |
-1,695
| Closed | -$214K | – | 2901 |
|
|
2025
Q2 | $214K | Hold |
1,695
| – | – | ﹤0.01% | 2639 |
|
|
2025
Q1 | $217K | Hold |
1,695
| – | – | ﹤0.01% | 2581 |
|
|
2024
Q4 | $224K | Sell |
1,695
-300
| -15% | -$42.2K | ﹤0.01% | 2659 |
|
|
2024
Q3 | $290K | Sell |
1,995
-1,675
| -46% | -$242K | ﹤0.01% | 2366 |
|
|
2024
Q2 | $504K | Buy |
3,670
+1,175
| +47% | +$157K | ﹤0.01% | 1959 |
|
|
2024
Q1 | $342K | Sell |
2,495
-300
| -11% | -$41K | ﹤0.01% | 2344 |
|
|
2023
Q4 | $380K | Sell |
2,795
-883
| -24% | -$108K | ﹤0.01% | 2174 |
|
|
2023
Q3 | $450K | Buy |
3,678
+222
| +6% | +$28.2K | ﹤0.01% | 2020 |
|
|
2023
Q2 | $439K | Buy |
3,456
+500
| +17% | +$65K | ﹤0.01% | 2013 |
|
|
2023
Q1 | $381K | Buy |
2,956
+500
| +20% | +$65.5K | ﹤0.01% | 2137 |
|
|
2022
Q4 | $321K | Sell |
2,456
-3,278
| -57% | -$424K | ﹤0.01% | 2504 |
|
|
2022
Q3 | $676K | Sell |
5,734
-14,956
| -72% | -$1.86M | ﹤0.01% | 2023 |
|
|
2022
Q2 | $2.44M | Sell |
20,690
-743
| -3% | -$88.2K | ﹤0.01% | 1489 |
|
|
2022
Q1 | $2.8M | Buy |
21,433
+3,789
| +21% | +$494K | ﹤0.01% | 1452 |
|
|
2021
Q4 | $2.7M | Sell |
17,644
-834
| -5% | -$129K | ﹤0.01% | 1550 |
|
|
2021
Q3 | $2.99M | Sell |
18,478
-1,857
| -9% | -$313K | ﹤0.01% | 1370 |
|
|
2021
Q2 | $3.33M | Buy |
20,335
+1,732
| +9% | +$267K | ﹤0.01% | 1253 |
|
|
2021
Q1 | $2.8M | Buy |
18,603
+5,694
| +44% | +$904K | ﹤0.01% | 1203 |
|
|
2020
Q4 | $1.96M | Sell |
12,909
-630
| -5% | -$90K | ﹤0.01% | 1341 |
|
|
2020
Q3 | $1.83M | Buy |
13,539
+899
| +7% | +$122K | ﹤0.01% | 1305 |
|
|
2020
Q2 | $1.73M | Sell |
12,640
-1,818
| -13% | -$232K | ﹤0.01% | 1215 |
|
|
2020
Q1 | $1.56M | Buy |
14,458
+706
| +5% | +$81.3K | ﹤0.01% | 1280 |
|
|
2019
Q4 | $1.66M | Sell |
13,752
-120
| -0.9% | -$13.4K | ﹤0.01% | 1578 |
|
|
2019
Q3 | $1.38M | Sell |
13,872
-150
| -1% | -$15.7K | ﹤0.01% | 1792 |
|
|
2019
Q2 | $1.53M | Sell |
14,022
-39,132
| -74% | -$4.16M | ﹤0.01% | 1633 |
|
|
2019
Q1 | $5.94M | Sell |
53,154
-39,064
| -42% | -$4.28M | 0.01% | 1039 |
|
|
2018
Q4 | $8.89M | Buy |
92,218
+41,459
| +82% | +$4.4M | 0.02% | 879 |
|
|
2018
Q3 | $6.19M | Sell |
50,759
-2,907
| -5% | -$342K | 0.01% | 1041 |
|
|
2018
Q2 | $5.89M | Sell |
53,666
-1,127
| -2% | -$121K | 0.01% | 1043 |
|
|
2018
Q1 | $5.85M | Sell |
54,793
-67,383
| -55% | -$7.47M | 0.01% | 1052 |
|
|
2017
Q4 | $13M | Buy |
122,176
+95,521
| +358% | +$10.2M | 0.02% | 610 |
|
|
2017
Q3 | $2.96M | Sell |
26,655
-21,495
| -45% | -$2.3M | ﹤0.01% | 1195 |
|
|
2017
Q2 | $4.98M | Buy |
48,150
+24,594
| +104% | +$2.42M | 0.01% | 981 |
|
|
2017
Q1 | $2.3M | Sell |
23,556
-35,952
| -60% | -$3.44M | ﹤0.01% | 1184 |
|
|
2016
Q4 | $5.26M | Buy |
59,508
+726
| +1% | +$66.1K | 0.01% | 910 |
|
|
2016
Q3 | $5.67M | Sell |
58,782
-48,771
| -45% | -$4.64M | 0.01% | 872 |
|
|
2016
Q2 | $9.22M | Buy |
107,553
+74,898
| +229% | +$6.72M | 0.03% | 678 |
|
|
2016
Q1 | $2.84M | Buy |
32,655
+114
| +0.4% | +$10.2K | 0.01% | 1060 |
|
|
2015
Q4 | $3.67M | Sell |
32,541
-70,629
| -68% | -$7.67M | 0.01% | 1043 |
|
|
2015
Q3 | $10.4M | Buy |
103,170
+80,715
| +359% | +$9.68M | 0.03% | 586 |
|
|
2015
Q2 | $2.76M | Sell |
22,455
-10,545
| -32% | -$1.26M | 0.01% | 992 |
|
|
2015
Q1 | $3.78M | Buy |
33,000
+3,177
| +11% | +$350K | 0.01% | 1004 |
|
|
2014
Q4 | $3.02M | Sell |
29,823
-1,329
| -4% | -$129K | 0.01% | 1051 |
|
|
2014
Q3 | $2.84M | Sell |
31,152
-7,053
| -18% | -$619K | 0.01% | 1058 |
|
|
2014
Q2 | $3.27M | Buy |
38,205
+18,630
| +95% | +$1.47M | 0.01% | 981 |
|
|
2014
Q1 | $1.54M | Buy |
19,575
+4,500
| +30% | +$375K | ﹤0.01% | 1134 |
|
|
2013
Q4 | $1.14M | Buy |
15,075
+2,070
| +16% | +$147K | ﹤0.01% | 1237 |
|
|
2013
Q3 | $911K | Sell |
13,005
-9,870
| -43% | -$647K | ﹤0.01% | 1250 |
|
|
2013
Q2 | $1.33M | Buy |
+22,875
| New | +$1.32M | ﹤0.01% | 1027 |
|
Other funds holding IBB
CB
HSBC Holdings's IBB Position: Q1 2026 in Review
HSBC Holdings increased its iShares Biotechnology ETF (IBB) stake by 15% in Q1 2026, buying an estimated $78.5K and bringing the position to 3,617 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #2127.
HSBC Holdings first reported a position in IBB in Q2 2013 and has held it in 51 quarters since. The position peaked at $13M in Q4 2017. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- HSBC Holdings held 3,617 shares of iShares Biotechnology ETF worth $610K as of Q1 2026.
- HSBC Holdings bought 459 iShares Biotechnology ETF shares in Q1 2026, an estimated $78.5K.
- iShares Biotechnology ETF made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2127 holding.
- HSBC Holdings first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 51 quarters since.
- HSBC Holdings's iShares Biotechnology ETF position peaked at $13M in Q4 2017.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.